GulfSea Cylcare XP 5040 2023 July 24 GulfSea Cylcare XP 5040X SGP en 0
GulfSea Cylcare XP 5040 2023 July 24 GulfSea Cylcare XP 5040X SGP en 0
Product Identifier
Product name GulfSea Cylcare XP 5040
Chemical Name Not Applicable
Synonyms Not Available
Chemical formula Not Applicable
Other means of identification GulfSea Cylcare XP 5040X
Relevant identified uses of the substance or mixture and uses advised against
Marine cylinder oil.
Relevant identified uses
Use according to manufacturer's directions.
Label elements
Hazard pictogram(s)
Hazard statement(s)
H317 May cause an allergic skin reaction.
Page 1 continued...
Chemwatch: 5602-99 Page 2 of 13 Issue Date: 24/07/2023
Part Number: Print Date: 14/06/2024
GulfSea Cylcare XP 5040
Version No: 3.1
P272 Contaminated work clothing should not be allowed out of the workplace.
Substances
See section below for composition of Mixtures
Mixtures
CAS No %[weight] Name
63748-98-1 1-10 mineral oil
Not Available containing one or more of the following:
64742-54-7. paraffinic distillate, heavy, hydrotreated (severe)
64742-65-0. paraffinic distillate, heavy, solvent-dewaxed (severe)
64742-55-8. paraffinic distillate, light, hydrotreated (severe)
64742-56-9. paraffinic distillate, light, solvent-dewaxed (severe)
1078715-97-5 1-10 calcium sulfonate
4259-15-8 <1 zinc bis(2-ethylhexyl)dithiophosphate
121158-58-5 <1 dodecylphenol, branched
Not Available balance Ingredients determined not to be hazardous
Extinguishing media
Foam.
Dry chemical powder.
BCF (where regulations permit).
Carbon dioxide.
Water spray or fog - Large fires only.
Continued...
Chemwatch: 5602-99 Page 3 of 13 Issue Date: 24/07/2023
Part Number: Print Date: 14/06/2024
GulfSea Cylcare XP 5040
Version No: 3.1
Environmental precautions
See section 12
Continued...
Chemwatch: 5602-99 Page 4 of 13 Issue Date: 24/07/2023
Part Number: Print Date: 14/06/2024
GulfSea Cylcare XP 5040
Version No: 3.1
Check all containers are clearly labelled and free from leaks.
Storage incompatibility Avoid reaction with oxidising agents
Control parameters
Emergency Limits
Ingredient TEEL-1 TEEL-2 TEEL-3
mineral oil 140 mg/m3 1,500 mg/m3 8,900 mg/m3
paraffinic distillate, heavy,
140 mg/m3 1,500 mg/m3 8,900 mg/m3
hydrotreated (severe)
paraffinic distillate, heavy,
140 mg/m3 1,500 mg/m3 8,900 mg/m3
solvent-dewaxed (severe)
paraffinic distillate, light,
140 mg/m3 1,500 mg/m3 8,900 mg/m3
hydrotreated (severe)
paraffinic distillate, light,
140 mg/m3 1,500 mg/m3 8,900 mg/m3
solvent-dewaxed (severe)
dodecylphenol, branched 4.1 mg/m3 45 mg/m3 420 mg/m3
Exposure controls
Appropriate engineering Engineering controls are used to remove a hazard or place a barrier between the worker and the hazard. Well-designed engineering controls
controls can be highly effective in protecting workers and will typically be independent of worker interactions to provide this high level of protection.
The basic types of engineering controls are:
Process controls which involve changing the way a job activity or process is done to reduce the risk.
Enclosure and/or isolation of emission source which keeps a selected hazard "physically" away from the worker and ventilation that
strategically "adds" and "removes" air in the work environment. Ventilation can remove or dilute an air contaminant if designed properly. The
design of a ventilation system must match the particular process and chemical or contaminant in use.
Employers may need to use multiple types of controls to prevent employee overexposure.
General exhaust is adequate under normal operating conditions. Local exhaust ventilation may be required in specific circumstances. If risk
of overexposure exists, wear approved respirator. Correct fit is essential to obtain adequate protection. Provide adequate ventilation in
Continued...
Chemwatch: 5602-99 Page 5 of 13 Issue Date: 24/07/2023
Part Number: Print Date: 14/06/2024
GulfSea Cylcare XP 5040
Version No: 3.1
warehouse or closed storage areas. Air contaminants generated in the workplace possess varying "escape" velocities which, in turn,
determine the "capture velocities" of fresh circulating air required to effectively remove the contaminant.
Simple theory shows that air velocity falls rapidly with distance away from the opening of a simple extraction pipe. Velocity generally
decreases with the square of distance from the extraction point (in simple cases). Therefore the air speed at the extraction point should be
adjusted, accordingly, after reference to distance from the contaminating source. The air velocity at the extraction fan, for example, should be
a minimum of 1-2 m/s (200-400 f/min) for extraction of solvents generated in a tank 2 meters distant from the extraction point. Other
mechanical considerations, producing performance deficits within the extraction apparatus, make it essential that theoretical air velocities are
multiplied by factors of 10 or more when extraction systems are installed or used.
Individual protection
measures, such as personal
protective equipment
Continued...
Chemwatch: 5602-99 Page 6 of 13 Issue Date: 24/07/2023
Part Number: Print Date: 14/06/2024
GulfSea Cylcare XP 5040
Version No: 3.1
Overalls.
P.V.C apron.
Other protection Barrier cream.
Skin cleansing cream.
Eye wash unit.
Respiratory protection
Type A-P Filter of sufficient capacity. (AS/NZS 1716 & 1715, EN 143:2000 & 149:2001, ANSI Z88 or national equivalent)
Where the concentration of gas/particulates in the breathing zone, approaches or exceeds the "Exposure Standard" (or ES), respiratory protection is required.
Degree of protection varies with both face-piece and Class of filter; the nature of protection varies with Type of filter.
Required Minimum Protection Factor Half-Face Respirator Full-Face Respirator Powered Air Respirator
up to 10 x ES A-AUS P2 - A-PAPR-AUS / Class 1 P2
up to 50 x ES - A-AUS / Class 1 P2 -
up to 100 x ES - A-2 P2 A-PAPR-2 P2 ^
^ - Full-face
A(All classes) = Organic vapours, B AUS or B1 = Acid gasses, B2 = Acid gas or hydrogen cyanide(HCN), B3 = Acid gas or hydrogen cyanide(HCN), E = Sulfur dioxide(SO2), G =
Agricultural chemicals, K = Ammonia(NH3), Hg = Mercury, NO = Oxides of nitrogen, MB = Methyl bromide, AX = Low boiling point organic compounds(below 65 degC)
Cartridge respirators should never be used for emergency ingress or in areas of unknown vapour concentrations or oxygen content.
The wearer must be warned to leave the contaminated area immediately on detecting any odours through the respirator. The odour may indicate that the mask is not
functioning properly, that the vapour concentration is too high, or that the mask is not properly fitted. Because of these limitations, only restricted use of cartridge respirators
is considered appropriate.
Cartridge performance is affected by humidity. Cartridges should be changed after 2 hr of continuous use unless it is determined that the humidity is less than 75%, in which
case, cartridges can be used for 4 hr. Used cartridges should be discarded daily, regardless of the length of time used
Continued...
Chemwatch: 5602-99 Page 7 of 13 Issue Date: 24/07/2023
Part Number: Print Date: 14/06/2024
GulfSea Cylcare XP 5040
Version No: 3.1
Skin contact is not thought to have harmful health effects (as classified under EC Directives); the material may still produce health damage
following entry through wounds, lesions or abrasions.
There is some evidence to suggest that this material can cause inflammation of the skin on contact in some persons.
Skin Contact
Open cuts, abraded or irritated skin should not be exposed to this material
Entry into the blood-stream, through, for example, cuts, abrasions or lesions, may produce systemic injury with harmful effects. Examine the
skin prior to the use of the material and ensure that any external damage is suitably protected.
The material may be irritating to the eye, with prolonged contact causing inflammation. Repeated or prolonged exposure to irritants may
Eye
produce conjunctivitis.
Skin contact with the material is more likely to cause a sensitisation reaction in some persons compared to the general population.
Chronic Substance accumulation, in the human body, may occur and may cause some concern following repeated or long-term occupational
exposure.
TOXICITY IRRITATION
GulfSea Cylcare XP 5040
Not Available Not Available
TOXICITY IRRITATION
mineral oil
Not Available Not Available
TOXICITY IRRITATION
[2]
paraffinic distillate, heavy, Dermal (rabbit) LD50: >2000 mg/kg Eye: no adverse effect observed (not irritating)[1]
[2]
hydrotreated (severe) Inhalation (Rat) LC50: 2.18 mg/l4h Skin: no adverse effect observed (not irritating)[1]
TOXICITY IRRITATION
Dermal (rabbit) LD50: >2000 mg/kg[2] Eye: no adverse effect observed (not irritating)[1]
paraffinic distillate, heavy,
solvent-dewaxed (severe) Inhalation (Rat) LC50: 2.18 mg/l4h[2] Skin: no adverse effect observed (not irritating)[1]
[2]
Oral (Rat) LD50: >5000 mg/kg
TOXICITY IRRITATION
Dermal (rabbit) LD50: >2000 mg/kg[2] Eye: no adverse effect observed (not irritating)[1]
paraffinic distillate, light,
[2]
hydrotreated (severe) Inhalation (Rat) LC50: 2.18 mg/l4h Skin: no adverse effect observed (not irritating)[1]
TOXICITY IRRITATION
[2]
Dermal (rabbit) LD50: >2000 mg/kg Eye: no adverse effect observed (not irritating)[1]
paraffinic distillate, light,
solvent-dewaxed (severe) Inhalation (Rat) LC50: 2.18 mg/l4h[2] Skin: no adverse effect observed (not irritating)[1]
[2]
Oral (Rat) LD50: >5000 mg/kg
TOXICITY IRRITATION
dermal (rat) LD50: >2000 mg/kg[1] Eye: no adverse effect observed (not irritating)[1]
calcium sulfonate
[1]
Inhalation (Rat) LC50: >1.9 mg/l4h Skin: no adverse effect observed (not irritating)[1]
TOXICITY IRRITATION
zinc bis(2- [2]
Dermal (rabbit) LD50: >5000 mg/kg Eye: adverse effect observed (irritating)[1]
ethylhexyl)dithiophosphate
[1]
Oral (Rat) LD50: >2000<5000 mg/kg Skin: no adverse effect observed (not irritating)[1]
TOXICITY IRRITATION
[1]
dodecylphenol, branched Dermal (rabbit) LD50: >2000 mg/kg Eye: adverse effect observed (irritating)[1]
[1]
Oral (Rat) LD50: <5000 mg/kg Skin: adverse effect observed (irritating)[1]
Legend: 1. Value obtained from Europe ECHA Registered Substances - Acute toxicity 2. Value obtained from manufacturer's SDS. Unless otherwise
specified data extracted from RTECS - Register of Toxic Effect of chemical Substances
Animal studies indicate that normal, branched and cyclic paraffins are absorbed from the gastrointestinal tract and that the absorption
of n-paraffins is inversely proportional to the carbon chain length, with little absorption above C30. With respect to the carbon chain
lengths likely to be present in mineral oil, n-paraffins may be absorbed to a greater extent than iso- or cyclo-paraffins.
PARAFFINIC DISTILLATE, HEAVY, The major classes of hydrocarbons are well absorbed into the gastrointestinal tract in various species. In many cases, the hydrophobic
SOLVENT-DEWAXED (SEVERE) hydrocarbons are ingested in association with fats in the diet. Some hydrocarbons may appear unchanged as in the lipoprotein
particles in the gut lymph, but most hydrocarbons partly separate from fats and undergo metabolism in the gut cell. The gut cell may
play a major role in determining the proportion of hydrocarbon that becomes available to be deposited unchanged in peripheral tissues
such as in the body fat stores or the liver.
PARAFFINIC DISTILLATE, LIGHT,
* Q8 MSDS
HYDROTREATED (SEVERE)
CALCIUM SULFONATE The following information refers to contact allergens as a group and may not be specific to this product.
Contact allergies quickly manifest themselves as contact eczema, more rarely as urticaria or Quincke's oedema. The pathogenesis of
contact eczema involves a cell-mediated (T lymphocytes) immune reaction of the delayed type. Other allergic skin reactions, e.g.
contact urticaria, involve antibody-mediated immune reactions. The significance of the contact allergen is not simply determined by its
sensitisation potential: the distribution of the substance and the opportunities for contact with it are equally important. A weakly
Continued...
Chemwatch: 5602-99 Page 8 of 13 Issue Date: 24/07/2023
Part Number: Print Date: 14/06/2024
GulfSea Cylcare XP 5040
Version No: 3.1
sensitising substance which is widely distributed can be a more important allergen than one with stronger sensitising potential with
which few individuals come into contact. From a clinical point of view, substances are noteworthy if they produce an allergic test
reaction in more than 1% of the persons tested.
Animal studies show that calcium sulfonates with a TBN greater than 300 are not skin sensitisers while the results in animals at a TBN
(Total Base Number) of 300 exhibit a mixed skin sensitisation response. However, human repeat insult patch tests clearly show that
high TBN overbased calcium sulfonates (TBN = 300) are not sensitisers and that low TBN calcium sulfonates do not cause
sensitisation in a substantial number of persons at concentrations of 10% or lower within the definition of sensitisation under EU
Regulation (EC) No. 1272/2008.
The weight-of-evidence indicates that low TBN sodium and calcium sulfonates (TBN < 300) are skin sensitisers with a specific
concentration limit (SCL) of 10% and that high TBN sodium and calcium sulfonates (TBN = 300) are not skin sensitisers. Studies in
guinea pigs show that low TBN benzenesulfonic acid, mono-C20-24 (even)-sec-alkyl derivs., para-, sodium salts (EC No. None; CAS
No. None; TBN = 3) is a skin sensitizer while benzenesulfonic acid, mono-C20-24 (even)-sec-alkyl derivs., para-, sodium salts TBN =
448) is not a skin sensitiser. Studies in guinea pigs and human volunteers show that low TBN benzenesulfonic acid, 4-(mono-C15 -36
branched alkyl derivs., C24 rich) and benzenesulfonic acid, 4-octadecyl, calcium salts (EC 939-141-9; TBN = 13) are skin sensitisers.
Numerous well-conducted, reliable, controlled human (HRIPT) studies with benzene, polypropene derivs., sulfonated, calcium salts (EC
616-278-7; TBN values ranging from 13 to 85), sulfonic acids, petroleum, calcium salts (EC 263-093-9; TBN = 30 to 100), and
benzenesulfonic acid, 4-(mono-C15-36 branched alkyl derivs., C24 rich) and benzenesulfonic acid, 4-octadecyl, calcium salts (EC 939-
141-6; TBN = 13) show that low TBN calcium sulfonates do not cause sensitisation in a substantial number of subjects at 10% and
lower. High TBN calcium sulfonates, sulfonic acids, petroleum, calcium salts (EC 263-093-9; TBN = 375 and 400) do not cause skin
sensitisation in guinea pigs. Results of guinea pigs studies at TBN = 300 are mixed; two studies of sulfonic acids, petroleum, calcium
salts, (EC 263-093-9) report no skin sensitisation while one study of sulfonic acids, petroleum, calcium salts (EC 263-093-9) and one
study of benzene, polypropene derivs., sulfonated, calcium salts (EC 616-278-7) report skin sensitisation, However, numerous well-
conducted, reliable, controlled human (HRIPT) studies with benzene, polypropene derivs., sulfonated, calcium salts (EC 616-278-7;
TBN = 300) and sulfonic acids, petroleum, calcium salts (EC 263-093-9; TBN = 300) also show that high TBN (TBN = 300) do not
cause skin sensitisation. In accordance with EU CLP Regulation (EC) No. 1272/2008, classification is required for low TBN sodium and
calcium sulfonates (TBN < 300) with a specific concentration limit of 10% and classification is not required for high TBN calcium
sulfonates (TBN = 300).
The material may produce severe irritation to the eye causing pronounced inflammation. Repeated or prolonged exposure to irritants
may produce conjunctivitis.
Dithiophosphate alkyl esters is corrosive and toxic to the tissues on skin or oral exposure depending on its concentration. Symptoms
ZINC BIS(2-
included diarrhoea, skin and gastrointestinal irritation, lethargy, reduced food intake, staining about the nose and eye; occasionally,
ETHYLHEXYL)DITHIOPHOSPHATE
there was drooping of the eyelid, hair standing up, inco-ordination and salivation. Toxicity is reduced following inhalation (due to vapour
pressure and high viscosity). It may produce reproductive, developmental and genetic toxicity on experimental animals, but no
substantive data is available to establish effect on humans.
DODECYLPHENOL, BRANCHED Asthma-like symptoms may continue for months or even years after exposure to the material ends. This may be due to a non-allergic
condition known as reactive airways dysfunction syndrome (RADS) which can occur after exposure to high levels of highly irritating
compound. Main criteria for diagnosing RADS include the absence of previous airways disease in a non-atopic individual, with sudden
onset of persistent asthma-like symptoms within minutes to hours of a documented exposure to the irritant. Other criteria for diagnosis
of RADS include a reversible airflow pattern on lung function tests, moderate to severe bronchial hyperreactivity on methacholine
challenge testing, and the lack of minimal lymphocytic inflammation, without eosinophilia. RADS (or asthma) following an irritating
inhalation is an infrequent disorder with rates related to the concentration of and duration of exposure to the irritating substance. On the
other hand, industrial bronchitis is a disorder that occurs as a result of exposure due to high concentrations of irritating substance (often
particles) and is completely reversible after exposure ceases. The disorder is characterized by difficulty breathing, cough and mucus
production.
for tetrapropenyl phenol and its derivatives.
The chemical possesses properties indicating a potential hazard for human health (effects on fertility and developmental toxicity at
doses that also cause maternal toxicity). Adequate screening-level data are available to characterize the human health hazard for the
purposes of the OECD Cooperative Chemicals Assessment Programme
SID Initial Assessment Profile (SIAM 22, 18-21 April 2006)
for para-C12-alkylphenols (typically tetrapropenylphenol)
Based on the toxicological findings presented in this review, para-C12-alkylphenols do not appear to meet the EU criteria for
classification for acute toxicity by the oral and dermal routes of exposure, skin sensitisation, repeated dose toxicity or mutagenicity. No
information is available relating to acute toxicity via inhalation exposure, and carcinogenicity. The following characteristics do suggest
that the substance warrants consideration for classification:
Irritation: para-C12-alkylphenols apparently meet the EU criteria for classification as a skin irritant and a severe eye irritant.
Classification for corrosivity could be considered.
Reproductive toxicity: • Fertility: The treatment-related effects on fertility, with supporting pathological changes indicating site of
action, appear to meet the EU criteria for classification. The observation that the fertility effects only occurred in the presence of general
toxicity might need to be taken into account in deciding the most appropriate category. Overall, these findings suggest that category 2
classification for acute toxicity may be most appropriate, although arguments for category 3 might be considered.
Developmental toxicity: para-C12-alkylphenols caused craniofacial (cleft palate, 3 pups from 1 litter) and long bone malformations
(bent long bones) in rats, but only at doses that caused some non-specific maternal toxicity (reduced body weight gain). These findings
are not considered to be a secondary non- specific consequence of general toxicity and hence classification for developmental toxicity
should be considered. A decision on whether category 2 or 3 is most appropriate may need expert consideration.
Classification for the environment
The substance is classified by the producers as ‘dangerous to the environment (with the symbol N) with the following risk phrases:
R50/53: Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment
This is based on the following data:
· Aquatic toxicity: 48-hour Daphnia EC50 <1 mg/L;
· log Kow >3 and measured fish bioconcentration factor of 823;
· Not readily biodegradable.
Acute toxicity data for the oral route of exposure are available for the rat only. LD50 values of 2,100 and 2,200 mg/kg were obtained in
two separate studies. In one study, no deaths were observed with a single oral dose of 500 mg/kg but one rat at this dose level showed
bloody urine that persisted for 48 hours post-dosing. A NOAEL for the effects of a single oral dose cannot be determined. Signs of
toxicity observed in the acute oral toxicity studies included ruffled fur, diarrhoea, diuresis, retarded motion and ataxia.
Dermal: Two studies are available, both in rabbits. The findings indicate that deaths occur with doses above 3,160 mg/kg, and an LD50
of 15,000 mg/kg has been reported. Studies in rabbits indicate that tetrapropenylphenol is a severe skin irritant.
Eye: Studies in rabbits indicate that tetrapropenylphenol is an eye irritant capable of causing corneal opacity and iritis.
Respiratory tract: No data are available concerning respiratory tract irritancy. Given the evidence for skin and eye irritancy, it might be
expected that inhaled tetrapropenylphenol would irritate the respiratory tract.
Corrosivity: Necrosis and eschar formation have been reported following dermal application of tetrapropenylphenol to rabbits. From
the data available it is uncertain whether or not tetrapropenylphenol should be regarded as corrosive or as a severe skin irritant.
Sensitisation: Tetrapropenylphenol was not identified as a cause of skin sensitisation in two studies in guinea pigs
Repeated dose toxicity: Repeated dosing of tetrapropenylphenol to rats in oral studies, both dietary and gavage, produces effects in a
number of organs including the reproductive organs in both sexes.
In the 28-day gavage study in rats, no toxicologically significant treatment-related effects were observed at 5 mg/kg/day. At the next
higher dose of 20 mg/kg/day, adrenal cortical gland hypertrophy was observed in male rats. At 180 mg/kg/day and above, pathological
changes and organ weight changes were observed in a number of organs, including prominent changes in the reproductive organs in
both sexes.
In the dietary studies, effects on the testes were noted at 250 mg/kg/day (28-day study) and 106 mg/kg/day (90-day study). No
treatment-related toxicological effects were seen in the dietary studies at 25 and 28 mg/kg/day respectively.
No treatment-related changes were reported in dogs at doses up to 4,000 ppm in the diet (estimated by the author to be equivalent to
180 mg/kg/day assuming a body weight of 11 kg and a daily food consumption of 0.5 kg). The absence of treatment- related changes in
Continued...
Chemwatch: 5602-99 Page 9 of 13 Issue Date: 24/07/2023
Part Number: Print Date: 14/06/2024
GulfSea Cylcare XP 5040
Version No: 3.1
Toxicity
Continued...
Chemwatch: 5602-99 Page 10 of 13 Issue Date: 24/07/2023
Part Number: Print Date: 14/06/2024
GulfSea Cylcare XP 5040
Version No: 3.1
Legend: Extracted from 1. IUCLID Toxicity Data 2. Europe ECHA Registered Substances - Ecotoxicological Information - Aquatic Toxicity 4. US EPA,
Ecotox database - Aquatic Toxicity Data 5. ECETOC Aquatic Hazard Assessment Data 6. NITE (Japan) - Bioconcentration Data 7. METI
(Japan) - Bioconcentration Data 8. Vendor Data
Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
DO NOT discharge into sewer or waterways.
Bioaccumulative potential
Ingredient Bioaccumulation
dodecylphenol, branched MEDIUM (BCF = 850)
Mobility in soil
Ingredient Mobility
dodecylphenol, branched LOW (Log KOC = 382000)
Labels Required
Marine Pollutant NO
Air transport (ICAO-IATA / DGR): NOT REGULATED FOR TRANSPORT OF DANGEROUS GOODS
Continued...
Chemwatch: 5602-99 Page 11 of 13 Issue Date: 24/07/2023
Part Number: Print Date: 14/06/2024
GulfSea Cylcare XP 5040
Version No: 3.1
Sea transport (IMDG-Code / GGVSee): NOT REGULATED FOR TRANSPORT OF DANGEROUS GOODS
14.7.1. Transport in bulk according to Annex II of MARPOL and the IBC code
Not Applicable
14.7.2. Transport in bulk in accordance with MARPOL Annex V and the IMSBC Code
Product name Group
mineral oil Not Available
paraffinic distillate, heavy,
Not Available
hydrotreated (severe)
paraffinic distillate, heavy,
Not Available
solvent-dewaxed (severe)
paraffinic distillate, light,
Not Available
hydrotreated (severe)
paraffinic distillate, light,
Not Available
solvent-dewaxed (severe)
calcium sulfonate Not Available
zinc bis(2-
Not Available
ethylhexyl)dithiophosphate
dodecylphenol, branched Not Available
Safety, health and environmental regulations / legislation specific for the substance or mixture
paraffinic distillate, heavy, hydrotreated (severe) is found on the following regulatory lists
Chemical Footprint Project - Chemicals of High Concern List
International Agency for Research on Cancer (IARC) - Agents Classified by the IARC Monographs - Not Classified as Carcinogenic
Singapore Permissible Exposure Limits of Toxic Substances
paraffinic distillate, heavy, solvent-dewaxed (severe) is found on the following regulatory lists
Chemical Footprint Project - Chemicals of High Concern List
International Agency for Research on Cancer (IARC) - Agents Classified by the IARC Monographs - Not Classified as Carcinogenic
Singapore Permissible Exposure Limits of Toxic Substances
paraffinic distillate, light, hydrotreated (severe) is found on the following regulatory lists
Chemical Footprint Project - Chemicals of High Concern List
International Agency for Research on Cancer (IARC) - Agents Classified by the IARC Monographs - Not Classified as Carcinogenic
Singapore Permissible Exposure Limits of Toxic Substances
paraffinic distillate, light, solvent-dewaxed (severe) is found on the following regulatory lists
Chemical Footprint Project - Chemicals of High Concern List
International Agency for Research on Cancer (IARC) - Agents Classified by the IARC Monographs - Not Classified as Carcinogenic
Singapore Permissible Exposure Limits of Toxic Substances
Continued...
Chemwatch: 5602-99 Page 12 of 13 Issue Date: 24/07/2023
Part Number: Print Date: 14/06/2024
GulfSea Cylcare XP 5040
Version No: 3.1
Other information
Classification of the preparation and its individual components has drawn on official and authoritative sources as well as independent review by the Chemwatch Classification
committee using available literature references.
The SDS is a Hazard Communication tool and should be used to assist in the Risk Assessment. Many factors determine whether the reported Hazards are Risks in the
workplace or other settings. Risks may be determined by reference to Exposures Scenarios. Scale of use, frequency of use and current or available engineering controls must be
considered.
The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication and may be subject to modification
from time to time. It is the user's responsibility to verify that this Safety Data Sheet is current prior to use or application. The information given is designed only as a guidance for
safe handling, use, application, processing, storage, transportation, disposal and release and is not to be considered a warranty or quality specification. The information relates
only to the specific material designated and may not be valid for such material used in combination with any other materials or in any process, unless specified in the text.
Continued...
Chemwatch: 5602-99 Page 13 of 13 Issue Date: 24/07/2023
Part Number: Print Date: 14/06/2024
GulfSea Cylcare XP 5040
Version No: 3.1
end of SDS